Back to search
FDAFDA · Food and drugs·Recall number D-1086-2023

Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05

Published August 23, 2023 · Recall initiated: July 27, 2023

Summary

FDA records drug Class III recall D-1086-2023, published August 23, 2023 and initiated July 27, 2023. Recalling firm: ALEMBIC PHARMACEUTICALS, INC.; Status: Ongoing; Reported quantity: 82,400 bottles; Lot: Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if TOBRAMYCIN OPHTHALMIC SOLUTION has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TOBRAMYCIN OPHTHALMIC SOLUTION
Manufacturer
ALEMBIC PHARMACEUTICALS, INC.
Distributor
Nationwide in the USA
Lot
Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05 recalled?

Yes. FDA published recall D-1086-2023 on August 23, 2023. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TOBRAMYCIN OPHTHALMIC SOLUTION.